Volume 29, Issue 1 (Winter 2022)
Intern Med Today 2022, 29(1): 27-33 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aghakhani N, Ghaderi B, Alinezhad V, Baghaei R, Hazrati M. Effect of Enoxaparin Injection Duration on its Complications in Myocardial Infarction Patients. Intern Med Today 2022; 29 (1) :27-33
URL: http://imtj.gmu.ac.ir/article-1-3977-en.html
URL: http://imtj.gmu.ac.ir/article-1-3977-en.html
1- Associate Professor, Food and Beverage Safety Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
2- PhD in Nursing, Educational Supervisor of Shahid Madani Educational and Medical Center, Tabriz, Iran.
3- Assistant Professor of Biostatistics, Patient Safety Research Center, Clinical Sciences Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
4- Associate Professor, Faculty of Nursing and Midwifery, Urmia University of Medical Sciences, Urmia, Iran.
5- MSc in Nursing, Department of Intensive Care, Faculty of Nursing, Urmia University of Medical Sciences, Urmia, Iran. ,hazrati.m2018@gmail.com
2- PhD in Nursing, Educational Supervisor of Shahid Madani Educational and Medical Center, Tabriz, Iran.
3- Assistant Professor of Biostatistics, Patient Safety Research Center, Clinical Sciences Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
4- Associate Professor, Faculty of Nursing and Midwifery, Urmia University of Medical Sciences, Urmia, Iran.
5- MSc in Nursing, Department of Intensive Care, Faculty of Nursing, Urmia University of Medical Sciences, Urmia, Iran. ,
Abstract: (820 Views)
Aims Enoxaparin is a subcutaneous anticoagulant that has some side effects, including bruising and pain at the injection site. The incidence of the side effects can prevent the patient from continuing the treatment. Since one of the most important duties of nurses is the safe and low-complication injection of drugs, such as enoxaparin, this study aimed to examine the effect of the duration of enoxaparin subcutaneous injection on the intensity of pain and the incidence of bruising, as well as the size of it, in injection site among patients with myocardial infarction.
Materials & Methods This semi-experimental research was conducted on 56 patients treated with enoxaparin and hospitalized in the cardiac care unit of Shahid Madani Medical Training Center in Tabriz, Iran, in 2021. After an initial convenience sampling, the samples were divided into 2 groups by random allocation. Enoxaparin injections were done in all patients by the researcher. The injection was done within 10 and 30 s for the control and experimental groups, respectively. The intensity of pain was measured by a numerical pain rating scale immediately after each injection, and the incidence and size of bruising were assessed with a transparent ruler in square millimeters 48 hours after each injection. Data analysis was conducted in SPSS V. 22 at a significance level of 0.05.
Findings In the present study, the mean scores of pain intensity (P=0.0001), the incidence of bruising (P=0.029), and the size of the injection site bruise (P=0.044) were significantly lower in enoxaparin injection within 30 s than 10 s.
Conclusion: Due to the significant reduction in pain intensity and the incidence and size of bruises after increasing the duration of enoxaparin subcutaneous injection and, therefore, the improvement of the quality of care and reduction of the unpleasant and stressful experiences of patients, it is suggested to increase the duration of injection to 30 s.
Materials & Methods This semi-experimental research was conducted on 56 patients treated with enoxaparin and hospitalized in the cardiac care unit of Shahid Madani Medical Training Center in Tabriz, Iran, in 2021. After an initial convenience sampling, the samples were divided into 2 groups by random allocation. Enoxaparin injections were done in all patients by the researcher. The injection was done within 10 and 30 s for the control and experimental groups, respectively. The intensity of pain was measured by a numerical pain rating scale immediately after each injection, and the incidence and size of bruising were assessed with a transparent ruler in square millimeters 48 hours after each injection. Data analysis was conducted in SPSS V. 22 at a significance level of 0.05.
Findings In the present study, the mean scores of pain intensity (P=0.0001), the incidence of bruising (P=0.029), and the size of the injection site bruise (P=0.044) were significantly lower in enoxaparin injection within 30 s than 10 s.
Conclusion: Due to the significant reduction in pain intensity and the incidence and size of bruises after increasing the duration of enoxaparin subcutaneous injection and, therefore, the improvement of the quality of care and reduction of the unpleasant and stressful experiences of patients, it is suggested to increase the duration of injection to 30 s.
Type of Study: Applicable |
Subject:
Internal Medicine
Received: 2023/04/24 | Accepted: 2023/06/12 | Published: 2023/06/19
Received: 2023/04/24 | Accepted: 2023/06/12 | Published: 2023/06/19
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |